Browsing Tag
Ultragenyx Pharmaceutical
3 posts
Kyowa Kirin secures extended EC approval for CRYSVITA in X-linked hypophosphataemia treatment
Kyowa Kirin has recently received expanded approval from the European Commission (EC) for its recombinant monoclonal antibody treatment,…
October 4, 2020
Ultragenyx Pharmaceutical, Kyowa Kirin bag Crysvita FDA approval for TIO
Crysvita FDA approval for TIO : Ultragenyx Pharmaceutical and Kyowa Kirin have secured approval for their recombinant fully…
June 19, 2020
KIK-AS clinical trial : Angelman syndrome drug candidate GTX-102 to be evaluated by GeneTx Biotherapeutics
GeneTx Biotherapeutics is set to start the KIK-AS clinical trial for evaluating GTX-102 for the treatment of Angelman…
February 17, 2020